Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001140361-18-022841

EVP, Chief Financial Officer acquired 11,534 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINDAHL RICHARD S · EVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2018-05-08 Grant or award : show line 1 in the form +4,992 4,992 D
2018-05-08 Grant or award : show line 2 in the form +1,551 6,543 D
2018-05-08 Grant or award : show line 3 in the form +4,991 11,534 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-08 Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) +19,963 $48.33 $964,812 19,963 D
Loading xslF345X03/doc1.xml…